secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acadia Healthcare Company, Inc. (ACHC)
CIK:        0001520697
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001437749-26-005431
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO
--------------------------------------------------------------------------------

- Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.
- Adjusted EBITDA $99.8M (down 35% YoY) includes $52.7M PLGL reserve adjustment.
- FY 2025 adjusted EPS $2.00 vs $3.30; FY 2026 guidance: rev $3.37-3.45B, adj EPS $1.30-1.55.
- Debbie Osteen appointed CEO; full-year 2025 added 1,089 licensed beds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520697/000143774926005431/0001437749-26-005431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520697/000143774926005431/achc20260224_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-005431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer